In our analysis, we noted a negative association between signature 4 and KRAS p.G12D (c.35G>A) in lung adenocarcinoma where P = 0.0075 (S3 Table), which is just above our threshold for defining significance (P < 0.004). This evidence concerns the gene KRAS and lung adenocarcinoma.